JPRN-UMIN000030977
Completed
未知
Prospective evaluation of minimal residual disease in acute myeloid leukemia using TIM-3 as a leukemia marker - MRD study for acute myeloid leukemia using TIM-3 as a leukemic stem cell specific surface marker
Department of Medicine and Biosystemic Sciences, Kyushu University Graduate School of Medicine0 sites50 target enrollmentJanuary 24, 2018
Conditionsacute myeloid leukemia
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- acute myeloid leukemia
- Sponsor
- Department of Medicine and Biosystemic Sciences, Kyushu University Graduate School of Medicine
- Enrollment
- 50
- Status
- Completed
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- •(1\) Refractory or relapsed acute myeloid leukemia patients (2\)Secondary AML patients (3\)Acute promyelocytic leukemia patients (4\) A patient whom the researchers decide as an inappropriate case
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Not Applicable
Prognostic value of minimal residual disease detection by multiparameter flow cytometry (EuroFlow method) in patients with multiple myeloma who underwent autologous stem cell transplantation: comparison with sequencing-based methodmultiple myelomaJPRN-UMIN000022238Kanazawa University66
Completed
Not Applicable
Survey on Minimal Residual Disease (MRD) Measurement in Multiple MyelomaMultiple MyelomaJPRN-UMIN000052475Sanofi K.K.158
Completed
Not Applicable
Prognostic Role of Minimal Residual Disease in Acute Myeloid LeukemiaAcute Myeloid LeukemiaMinimal Residual DiseaseWilms TumorNCT02714790A.O.U. Città della Salute e della Scienza281
Recruiting
Not Applicable
Prospective evaluation of disease free survival and Quality of Life following microvascular reconstruction in early oral squamous cell carcinomaC06.9Mouth, unspecifiedDRKS00013041Klinik und Poliklinik für Mund-, Kiefer- und GesichtschirurgieKopfklinikUniversitätsklinikum Heidelberg50
Recruiting
Not Applicable
MRD-guided Prognosis Prediction and Adjuvant Treatment Based on CTC and ctDNA in NSCLCNon-small Cell Lung CancerNCT06198868Jiangsu Cancer Institute & Hospital60